33631-02-6 Usage
General Description
3,4-Diamino-2-hydroxypyridine, also known as 2-Amino-3,4-dihydroxypyridine, is a chemical compound commonly used in the pharmaceutical and cosmetics industries. It is a pyridine derivative with two amino groups and a hydroxy group attached to the aromatic ring. 3,4-Diamino-2-hydroxypyridine has demonstrated antioxidant and anti-inflammatory properties, making it a potential candidate for the treatment of various diseases and conditions. It is also commonly used in hair dyes and colorants, where it acts as a coloring agent. 3,4-Diamino-2-hydroxypyridine is a versatile chemical with a range of potential applications in multiple industries.
Check Digit Verification of cas no
The CAS Registry Mumber 33631-02-6 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 3,3,6,3 and 1 respectively; the second part has 2 digits, 0 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 33631-02:
(7*3)+(6*3)+(5*6)+(4*3)+(3*1)+(2*0)+(1*2)=86
86 % 10 = 6
So 33631-02-6 is a valid CAS Registry Number.
InChI:InChI=1/C7H6F3NO2S/c8-7(9,10)5-2-1-3-6(4-5)14(11,12)13/h1-4H,(H2,11,12,13)
33631-02-6Relevant articles and documents
3,4-DISUBSTITUTED PYRAZOLES AS CYCLIN DEPENDENT KINASES (CDK) OR AURORA KINASE OR GLYCOGEN SYNTHASE 3 (GSK-3) INHIBITORS
-
Page/Page column 149, (2008/06/13)
The invention provides compounds of the formula (I); or salts or solvates or N-oxides thereof; wherein: Rq is selected from groups (a), (b) and (c); the asterisk denoting the point of attachment to the pyrazole ring; X is N or CR5; X" is NR4', O, S or S(O); A is a bond or -(CH2)m-(B)n-; B is C=O, NRg(C=O) or O(C=O) wherein Rg is hydrogen or C1-4 hydrocarbyl optionally substituted by hydroxy or C1-4 alkoxy; m is 0, 1 or 2; n is 0 or 1; R0 is hydrogen or, together with NRg when present, forms a group -(CH2)p- wherein p is 2 to 4; and R1 to R6b are as defined in the description. Compounds of the formula (I) have activity as inhibitors of CDK, aurora and GSK-3 kinases are useful in treating or preventing diseases such as cancers that are mediated by the said kinases.